Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer Types.
Elliott A, Zhang J, Zhang Q, Swensen J, Martin D, Xiu J, Geynisman DM, Vaena D, Herzog TJ, Holloway RW, El-Deiry WS, Spetzler D, Heath E, Stafford P, Korn WM.
Elliott A, et al. Among authors: herzog tj.
J Mol Diagn. 2021 Dec;23(12):1761-1773. doi: 10.1016/j.jmoldx.2021.08.010. Epub 2021 Sep 22.
J Mol Diagn. 2021.
PMID: 34562615
Free article.